Down-regulation of angiogenic inhibitors: a potential pathogenic mechanism for diabetic complications.

Current diabetes reviews

Volumn 1, Issue 2, 2005, Pages 183-196

  Ma, Jian xing ^a   Zhang, Sarah X ^a   Wang, Joshua J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GROWTH PROMOTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

BIOLOGICAL MODEL; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DOWN REGULATION; GENETICS; HUMAN; INCIDENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANGIOGENESIS INHIBITORS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DOWN-REGULATION; GROWTH SUBSTANCES; HUMANS; INCIDENCE; MODELS, BIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845523580     PISSN: None     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/1573399054022839     Document Type: Review

References (182)